These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 14341128)

  • 1. EFFECT OF TESTOSTERONE ENANTHATE AND ALKYLATING AGENTS ON MULTIPLE MYELOMA.
    BRODSKY I; DENNIS LH; DECASTRO NA; BRADY L; KAHN SB
    JAMA; 1965 Sep; 193():874-8. PubMed ID: 14341128
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparative study with three alkylating agents: mechlorethamine, cyclophosphamide, and uracil mustard.
    GOLD GL; SALVIN LG; SHNIDER BI
    Cancer Chemother Rep; 1962 Feb; 16():417-9. PubMed ID: 13899670
    [No Abstract]   [Full Text] [Related]  

  • 3. [EXPERIMENTAL AND CLINICAL FINDINGS ON THE THERAPEUTIC USE OF A NEW ALKYLATING DRUG: URACIL MUSTARD].
    BALLERINI G; CASTOLDI G; RICCI N; TENZE L
    Clin Ter; 1965 Jan; 32():49-61. PubMed ID: 14262587
    [No Abstract]   [Full Text] [Related]  

  • 4. URACIL MUSTARY THERAPY IN METASTATIC WILMS'S TUMOR.
    VIETTI TJ; BERRY DH; FERNBACH DJ; LUSHER J; SUTOW WW
    Am J Dis Child; 1964 Nov; 108():530-2. PubMed ID: 14209688
    [No Abstract]   [Full Text] [Related]  

  • 5. URACIL MUSTARD: A POTENT INDUCER OF LUNG TUMORS IN MICE.
    ABELL CW; FALK HL; SHIMKIN MB; WEISBURGER EK; WEISBURGER JH; GUBAREFF N
    Science; 1965 Mar; 147(3664):1443-5. PubMed ID: 14268720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COLORIMETRIC METHOD FOR DETERMINATION OF URACIL MUSTARD AND RELATED ALKYLATING AGENTS.
    PETERING HG; VANGIESSEN GJ
    J Pharm Sci; 1963 Dec; 52():1159-62. PubMed ID: 14088966
    [No Abstract]   [Full Text] [Related]  

  • 7. PRACTICAL AND USEFUL DRUG THERAPY AGAINST CANCER.
    SAMP RJ
    SD J Med Pharm; 1964 Sep; 17():17-21. PubMed ID: 14174187
    [No Abstract]   [Full Text] [Related]  

  • 8. CLINICAL EVALUATION OF URACIL MUSTARD.
    WILLIAMS HM
    Cancer Chemother Rep; 1963 Oct; 32():73-6. PubMed ID: 14088838
    [No Abstract]   [Full Text] [Related]  

  • 9. COMPARATIVE PHARMACOLOGY OF ALKYLATING AGENTS. 3. TOXICITY DATA ON MONKEYS AND DOGS.
    SCHMIDT LH; FRADKIN R; SULLIVAN R; FLOWERS A
    Cancer Chemother Rep; 1965 Jan; 18():SUPPL 2:1017+. PubMed ID: 14278900
    [No Abstract]   [Full Text] [Related]  

  • 10. THERAPEUTIC EFFECT OF ANTICANCER DRUGS ON SKIN CANCER.
    HIGUCHI K; UEMATSU K
    Kyushu J Med Sci; 1963 Oct; 14():203-9. PubMed ID: 14104458
    [No Abstract]   [Full Text] [Related]  

  • 11. ANTICANCER AGENTS.
    NEWELL FW
    Invest Ophthalmol; 1964 Oct; 3():489-91. PubMed ID: 14229933
    [No Abstract]   [Full Text] [Related]  

  • 12. A STUDY OF COMPARATIVE CHEMICAL AND BIOLOGICAL ACTIVITIES OF ALKYLATING AGENTS.
    BARDOS TJ; DATTA-GUPTA N; HEBBORN P; TRIGGLE DJ
    J Med Chem; 1965 Mar; 8():167-74. PubMed ID: 14335145
    [No Abstract]   [Full Text] [Related]  

  • 13. TESTOSTERONE ENANTHATE (NSC-17591) AS A BONE MARROW STIMULANT DURING CANCER CHEMOTHERAPY--PRELIMINARY REPORT.
    BRODSKY I; DENNIS LH; KAHN SB
    Cancer Chemother Rep; 1964 Jan; 34():59-63. PubMed ID: 14116221
    [No Abstract]   [Full Text] [Related]  

  • 14. [REDUCING THE TOXICITY OF DOPAN BY MEANS OF AMINOETHYL-ISOTHIURONIUM (AET) IN EXPERIMENTS ON MONKEYS].
    SPASSKAIA IG; PLATONOVA GN; SOLOPAEVA IM; SEMENOV LF; ZEITUNIAN KA; LARIONOV LF
    Vopr Onkol; 1963; 9():44-6. PubMed ID: 14148614
    [No Abstract]   [Full Text] [Related]  

  • 15. [A CASE OF ACUTE POISONING WITH DOPAN].
    BOGORODSKAIA TA; MIKHAILOVA EN; OGIBINA LN; SHCHERBA MM
    Ter Arkh; 1965 Jan; 37():107-9. PubMed ID: 14342983
    [No Abstract]   [Full Text] [Related]  

  • 16. Uracil mustard, a new alkylating agent for oral administration in the management of patients with leukemia and lymphoma.
    KENNEDY BJ; THEOLOGIDES A
    N Engl J Med; 1961 Apr; 264():790-3. PubMed ID: 13752496
    [No Abstract]   [Full Text] [Related]  

  • 17. EXPERIMENTAL CHEMOTHERAPY STUDIES. IV. THE PROTECTIVE ACTION OF MERCAPTOALKYLAMINES AGAINST ALKYLATING AGENTS.
    RUTMAN RJ; LEWIS FS; PRICE CC
    Cancer Res; 1964 May; 24():626-33. PubMed ID: 14188465
    [No Abstract]   [Full Text] [Related]  

  • 18. MUTAGENESIS IN RELATION TO GENETIC HAZARDS IN MAN.
    FAHMY OG; FAHMY MJ
    Proc R Soc Med; 1964 Jul; 57(7):646-50. PubMed ID: 14178966
    [No Abstract]   [Full Text] [Related]  

  • 19. THE TREATMENT OF CANCER BY ISOLATION PERFUSION.
    DONALDSON SS; FLETCHER WS
    Am J Nurs; 1964 Aug; 64():81-4. PubMed ID: 14180364
    [No Abstract]   [Full Text] [Related]  

  • 20. [EXPERIMENTAL STUDIES ON CARCINOMA AND ITS ARRESTED STATE. 9. PHARMACOLOGY OF URACIL MUSTARD, A CHEMOTHERAPEUTIC ANTINEOPLASTIC AGENT].
    CHANG M
    Nihon Yakurigaku Zasshi; 1964 Sep; 60():413-34. PubMed ID: 14271233
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.